162 related articles for article (PubMed ID: 4566130)
1. [Clinical efficacy of nicergoline in cerebrovascular diseases. Statistical study].
Guardamagna C; Negri S
Minerva Cardioangiol; 1972 Nov; 20(11):636-41. PubMed ID: 4566130
[No Abstract] [Full Text] [Related]
2. [Clinical and electroencephalographic studies of the effect of nicergoline in cerebrovascular diseases].
Montanini R; Gasco P; Manfredini G
Acta Neurol (Napoli); 1973; 28(2):133-49. PubMed ID: 4575428
[No Abstract] [Full Text] [Related]
3. [Double-blind study based upon a quatitative appreciation scale of treating chronic cerebrovascular disorders].
Mémin Y; Najean Hueber E
Therapeutique; 1973 Nov; 49(9):605-8. PubMed ID: 4600040
[No Abstract] [Full Text] [Related]
4. [Polygraphic evaluation of a new vasoactive drug (nicergoline)].
Baturic P; Cirignotta F
Minerva Cardioangiol; 1973 Oct; 21(10):664-7. PubMed ID: 4589189
[No Abstract] [Full Text] [Related]
5. [The role of nicergoline in the symptomatic treatment of arterial hypertension and chronic cerebrovascular insufficiency. A study on 359 observations (author's transl)].
Dauverchain J
Arzneimittelforschung; 1979; 29(8a):1308-10. PubMed ID: 395956
[TBL] [Abstract][Full Text] [Related]
6. [Clinical use of a new vasoactive drug : nicergoline].
Mellini M
Minerva Med; 1973 May; 64(34):1844-53. PubMed ID: 4719381
[No Abstract] [Full Text] [Related]
7. [Use of sermion, Cavinton and trental in patients with cerebrovascular disorders].
Lebedeva NV; Khrapova EV
Sov Med; 1990; (1):60-3. PubMed ID: 2190329
[No Abstract] [Full Text] [Related]
8. [Preliminary study on the effect of a nicergoline composition (F.I. 6714) on cerebral blood flow].
Prencipe M; Cecconi V; Pisarri F
Farmaco Prat; 1974 May; 29(5):278-84. PubMed ID: 4152517
[No Abstract] [Full Text] [Related]
9. [Evaluation of the effectiveness and tolerance of the preparation Sermion in the treatment of selected retinal diseases].
Szaflik J; Jupowiecka A
Klin Oczna; 1985 Apr; 87(4):165-6. PubMed ID: 3900547
[No Abstract] [Full Text] [Related]
10. [Therapeutic action of nicergoline in the treatment of cerebrovascular and peripheral disorders].
Pasotti C; Liverta C; Cacciatori D; Pollini C
Farmaco Prat; 1974 Sep; 29(9):508-19. PubMed ID: 4608968
[No Abstract] [Full Text] [Related]
11. [Clinical study on treatment with nicergoline in a group of patients with hemiplegia in a post-acute phase].
Zucconi V; Bolaffio MT
Minerva Med; 1974 Mar; 65(17):936-45. PubMed ID: 4151126
[No Abstract] [Full Text] [Related]
12. [Therapeutic activity of nicergoline in cerebrovascular syndromes].
Toni E
Minerva Med; 1973 Nov; 64(84):4466-73. PubMed ID: 4771472
[No Abstract] [Full Text] [Related]
13. [Drug therapy of cerebrovascular and cardiac insufficiency].
Kief W; Schmidt-Modrow G
Med Welt; 1977 Oct; 28(42):1730-2. PubMed ID: 337039
[No Abstract] [Full Text] [Related]
14. [Trial of nicergoline in arteriopathies of the lower limbs (apropos of 33 cases)].
Debaert M; Ribet M; Quandalle P
Lille Med; 1981 Mar; 26(3):140-3. PubMed ID: 7289750
[No Abstract] [Full Text] [Related]
15. [Electroencephalography and psychometric measurements during the treatment of cerebral insufficiency with nicergoline and dihydroergotamine mesylate].
Kugler JE; Meurer-Krüll BC
Arzneimittelforschung; 1985; 35(12):1865-70. PubMed ID: 3913425
[TBL] [Abstract][Full Text] [Related]
16. [Controlled clinical study of the effects of Anasclerol in hospitalized patients with cerebrovascular disorders].
Riccardi T; Passeri F; Locatelli F
Minerva Med; 1978 Sep; 69(42):2873-8. PubMed ID: 358021
[TBL] [Abstract][Full Text] [Related]
17. [Neurophysiological study of 36 patients with cerebral vascular processes treated with nicergoline (author's transl)].
Samsó Dies JM; Villa Badó J; Villalobos J; Iriarte JL; Ordeix R
Arzneimittelforschung; 1979; 29(8a):1301-7. PubMed ID: 540075
[TBL] [Abstract][Full Text] [Related]
18. [Therapy of chronic cerebrovascular insufficiency. Controlled comparative study of 2 cerebral antihypoxidosis agents].
Szobor A; Klein M; Bräuer H
MMW Munch Med Wochenschr; 1982 Oct; 124(41):897-900. PubMed ID: 6815511
[No Abstract] [Full Text] [Related]
19. Cosaldon for vascular disorders?
Drug Ther Bull; 1972 Aug; 10(17):66-8. PubMed ID: 4570865
[No Abstract] [Full Text] [Related]
20. [Effects of nicergoline in peripheral arteriopathies of the lower limbs. Double-blind study].
Coscia M
Minerva Cardioangiol; 1972 Sep; 20(9):497-504. PubMed ID: 4561065
[No Abstract] [Full Text] [Related]
[Next] [New Search]
